We value your privacy

We use cookies to enhance your browsing experience, serve personalized content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy. By using this site you agree to our Terms and Conditions.

ortex-logo-h
​
​
Nasdaq:LYEL
​
​
logo

Lyell Immunopharma (LYEL)

Nasdaq • LYEL • US55083R2031

15.42Last close
Market Closed
Overview
Fundamentals
Events
News
Corp Actions
Index
Analysts
EPS Momentum
Holders
Dividend
Options
Shorts
Insiders
Peers
Commodity Exp
Trading Signals
Stock Scores

ORTEX Data Highlights

As of Oct 23, 2026, ORTEX estimated 14.4% of free float sold short, 8.7 days to cover, cost to borrow 0.64%. Sign up for live short interest data.

Market Cap

379m USD | # 6438 in US

Volume

169.9k shares | 2m USD

Shares Outstanding

24.59m

Free Float Shares

40.24% | 9.89m

News

LYEL key data

Lyell Immunopharma (Nasdaq: LYEL) has a market capitalization of $379.11M. Last close $15.42 (as of 2026-11-10); 52-week range $7.20 to $45.00. ORTEX data as of 2026-10-23: short interest was 14.36% of free float, 8.7 days to cover and the average cost to borrow was 0.64%. Sign up for live short interest data.

  • LYEL news on ORTEX News
  • ORTEX News
  • ORTEX public data
  • ORTEX Charts
  • ORTEX API

© 2026 ORTEX Technologies Ltd.